#USA #Richmond #BRAINBox Solutions #Pivotal Capital Partners #Prolight Diagnostics

BRAINBox Solutions Secures Strategic Financing for Concussion Testing Devices

In a significant move towards revolutionizing the diagnosis and management of concussions, BRAINBox Solutions has announced it has secured strategic financing aimed at accelerating the development of both point-of-care (PoC) and lab-based devices tailored for concussion diagnostics. This strategic development is essential for the company’s BRAINBox TBI diagnostic/prognostic tests, which are vital for identifying mild traumatic brain injuries commonly referred to as concussions.

The funding agreement includes equity investments as well as credit facilities provided by Pivotal Capital Partners and New Horizon Bank, though the precise financial terms have not been disclosed. According to Donna Edmonds, CEO of BRAINBox Solutions, this funding is a testament to the advancements the company has made in its proprietary assay formats, particularly through its collaboration with Prolight Diagnostics. This partnership has validated the suitability of Prolight’s Psyro® PoC platform for the TBI tests along with other neurological products in BRAINBox’s portfolio.

Innovations in Concussion Detection

BRAINBox further announced that this financing will allow the development of sophisticated hardware and software necessary for commercializing these essential diagnostic tools. The PoC device's development is a pivotal aspect of BRAINBox's strategy to ensure that concussion tests can be conducted in various settings, including hospital laboratories, clinics, ambulances, emergency rooms, nursing homes, and even athletic facilities.

“Having the support of Pivotal Capital and New Horizon Bank is crucial as their commitment to nurturing innovative and entrepreneurial enterprises aligns with our vision,” stated Edmonds. This initial backing promises a boost to the project as development progresses.

This new funding follows a comprehensive feasibility study in which Prolight assessed 260 patient samples sourced from BRAINBox's HeadSMART II pivotal trial, utilizing the Psyros platform to analyze three different assays for concussion detection. Remarkably, the study conveyed excellent performance results, enhancing the credibility of their research and product.

Prolight’s Pyros technology stands out for its ability to quickly detect and measure individual molecules derived from a single blood drop, showcasing its advanced capabilities to identify biomarkers at extremely low concentrations. This advancement is set to significantly enhance the diagnostics of concussive injuries, providing timely and life-saving information to medical professionals.

Leading in TBI Diagnosis

BRAINBox Solutions is pioneering an AI-enabled, multi-modality approach for the identification and prognosis of mild traumatic brain injuries. The firm aims to establish a standard for best practices in concussion diagnosis, providing crucial information for guiding medical interventions. The initial product in development aims to incorporate a panel of exclusive blood biomarkers that can be rapidly analyzed via point-of-care instruments or traditional laboratory systems. This device, alongside a digital neurocognitive testing platform, would yield a comprehensive TBI injury score, marking a significant leap in concussion management.

BRAINBox is backed by a team of leading physicians and scientists in the field, complemented by a management team focused on clinical excellence. As they continue to innovate and push boundaries within TBI research and diagnosis, they promise to set new standards in patient care.

To learn more about their initiatives and products, visit BRAINBox Solutions' official website.

Conclusion

The announcement from BRAINBox Solutions represents a stride towards more efficient and effective diagnostic solutions for concussions. With the backing of strategic partners and innovative technology at their disposal, BRAINBox Solutions is positioned to make a substantial impact in the realm of brain health and injury management.